Coordination of care: Ensure your GP, diabetes specialist, cardiologist, and pharmacist are all aware of your complete medication list and any changes in your health status
Not recommended while breastfeeding
This opened a regulatory door for federally licensed 503B compounding pharmacies to make products containing semaglutide or tirzepatide, the same active ingredients brand-name GLP-1 drugs
Signs That a Vial May No Longer Be Effective After Opening Even if you follow all the recommended guidelines, you should always inspect the vial before each use to ensure its still safe
This dual GIP/GLP-1 receptor agonist (Mounjaro, Zepbound) is not contraindicated in patients who have undergone cholecystectomy, as it does not depend on biliary function for its therapeutic action
Sean Wharton (Wharton Medical Clinic, lead study author)